A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
Clinical trial NCT06534411 · COMPLETED
Trial details
- NCT number
- NCT06534411
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-05
- Primary completion
- 2026-06-02
- Enrollment
- 1023
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.